Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

New England Journal of Medicine(2023)10.1056/nejmoa2206916Source: DataRank Database

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality is a dataset published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 6.0, placing it in the top 3.3% of the data-sharing corpus. It has been cited 814 times, with 100 citing works in its 1-hop citation network.

Top 3%percentile

6.0DataRank

Ranks in the top 3% for downstream scientific impact

Data paper Open Access814 citations · 100 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 124.55)OA: greenTopics (96)IDs (PubMed, OpenAlex)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 17%Citation Network 83%

Base Score Contribution

1.0

From this paper's citation signal

Citation Network Contribution

5.0

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
New England Journal of Medicine2025122 citations17 referencesContributes 0.283
Coordinating Efforts to Reduce the Global Incidence of Cardiovascular Disease
New England Journal of Medicine202321 citations11 referencesContributes 0.281
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
The Lancet2024223 citations29 referencesContributes 0.187
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial
Heart202444 citations21 referencesContributes 0.181
Smoking Cessation and Short- and Longer-Term Mortality
NEJM Evidence202470 citations25 referencesContributes 0.171

Authors (1)

The Global Cardiovascular Risk Consortium

Live enrichment

PubMed:37632466 OpenAlex:https://openalex.org/W4386194106

European Union AFFECT-EU

Grant: Horizon 2020, No. 847770

German Center for Cardiovascular Research

Grant: not applicable

European Union MORGAM

Grant: Biomed, BMH4-CT98-3183

European Union GenomEUtwin

Grant: FP5, QLG2-CT-2002-01254

European Union ENGAGE

Grant: FP7, HEALTH-F4-2007-201413

European Union CHANCES

Grant: FP7, HEALTH-F3-2010-242244

European Union BiomarCaRE

Grant: FP7, HEALTH-F2-2011-278913

European Union euCanSHare

Grant: Horizon 2020, No. 825903

European Commission

Grant: 825903

An EU-Canada joint infrastructure for next-generation multi-Study Heart research

European Commission

Grant: 847770

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

Medical Research Council

Grant: MC_UU_00027/5

Medical Research Council

Grant: G0601463

British Heart Foundation

Grant: RG/19/4/34452

Intramural VA

Grant: VA999999

Medical Research Council

Grant: MC_UU_00033/1

Intramural NIH HHS

Grant: Z99 HL999999

British Heart Foundation

Grant: RG/13/16/30528

Medical Research Council

Grant: MR/K019708/1

FWCI

124.55

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: cc-by

repositoryhttps://pure.qub.ac.uk/en/publications/95c9750c-22ed-4929-9dc6-c1406471ca66

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2206916

journalhttps://doi.org/10.1056/nejmoa2206916

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37632466

Fields of Study

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention0302 clinical medicine03 medical and health sciencesFemaleHumansMaleMiddle AgedCardiovascular DiseasesDiabetes MellitusRisk FactorsSmokingHeart Disease Risk FactorsInternationality

MeSH Terms

Heart Disease Risk FactorsCardiovascular DiseasesDiabetes MellitusFemaleHumansMaleMiddle AgedRisk FactorsSmokingInternationality

Keywords

MedicineBody mass indexPopulationIncidence (geometry)DiseaseConfidence intervalProportional hazards modelBlood pressureDiabetes mellitusDemographyCohort studyEpidemiologyRisk factorCohortAttributable riskInternal medicineEnvironmental healthEndocrinologyInternational Public HealthMaleMedicin och hälsovetenskapMedical SciencesInternationalityDiseasesBiochemistryMedical and Health SciencesGeographical comparisonRisk FactorsCardiovascular DiseaseMedical SpecialtiesMedicine and Health Sciences/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-beingCardiovascular risk factorsRisk factor modificationDiabetesSmokingModifiable Risk FactorsGlobalMiddle AgedLipidsCoronary heart diseaseStroke[SDV] Life Sciences [q-bio]Cardiology GeneralCardiovascular DiseasesHypertension/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalePublic HealthBiophysicsCardiology610Heart diseasePublic Health GeneralArticleBiomedical InformaticsCardiology; Cardiology General; Coronary Disease/Myocardial Infarction; Diabetes; Endocrinology; Hypertension; Lipids; Obesity; Prevention; Public Health; Public Health General;Coronary Disease/Myocardial Infarction/dk/atira/pure/subjectarea/asjc/2700/2700HumansObesityname=General MedicineMortalityPreventionCommunity Health and Preventive Medicinename=SDG 3 - Good Health and Well-beingMyocardial infarction[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHeart Disease Risk Factorsand Structural BiologyPopulation-attributable fraction

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being